Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
about
The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinomaApoptotic pathways as a therapeutic target for colorectal cancer treatmentNecroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyChemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumorsEssential versus accessory aspects of cell death: recommendations of the NCCD 2015.Bosellia serrata-induced apoptosis is related with ER stress and calcium release.Oblimersen for the treatment of patients with chronic lymphocytic leukemia.Inhibition of SREBP1 sensitizes cells to death ligands.Cell deathThe C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor.Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice.miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells.Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cellsLow-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo studyRegulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy.Detection of Anticancer and Apoptotic Effect of the Produced IgYs against the Three Extracellular Domain of Human DR5 Protein.Autophagy as a therapeutic target in cancer.Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells.Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1.Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cellsDNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosisSpy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD.Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activationBAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.Mir-375 enhances ruthenium-derived compound Rawq01 induced cell death in human ovarian cancerIdentification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.Computational structure-activity relationship analysis of non-peptide inducers of macrophage tumor necrosis factor-alpha production.The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damageTo kill a tumor cell: the potential of proapoptotic receptor agonistsImage analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sectionsTAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP.P2X7-mediated chemoprevention of epithelial cancers.Mitochondrial signaling in cell death via the Bcl-2 family.Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: the next step forward or two steps back?
P2860
Q24653562-E8817610-2E90-403E-9018-F5172A159B00Q26738304-4A5C637F-3C76-44C1-977B-6B8220831CBEQ26739959-DB0461C2-4755-4BF3-8027-BC1534D54ADEQ28474893-63A3BC5E-6A4D-4C11-B5E0-9B0E3D8DCCA7Q30408769-66190685-E0B6-4D2A-A6B6-50E46BB30D2BQ33375390-34A163F4-297F-434D-A81E-09E836DCE9ABQ33379565-DB57F9D0-173E-485E-B988-5CC24902845CQ33846866-21DFC386-2F9A-4EE3-A62D-91EB7C0998EAQ34019760-E223F641-8944-4FA8-9777-3BD843EFF514Q34081110-D3AC8836-132A-4561-AF37-B011E81E0E2BQ34091455-957D74C2-D1C6-4226-B18E-0ECDFDC0F954Q34160439-A0345DE1-7D10-4DD9-B324-93F9304468CBQ34168014-EAE156DF-F295-4DCD-9A71-67F326B0B929Q34280097-7A989BE1-B0B9-4C00-81B4-8738969F74BEQ34430268-C10CC641-540F-4392-9F32-F793608A3CDCQ34646527-6488189D-FFC6-4D6F-82E3-212403383DCBQ34722346-12879316-EE63-44EE-A03E-8984A29DF0BCQ35213333-5F4E854F-9098-44B2-A184-47ACC737A25AQ35543789-302BA27F-FDF0-4906-BEAC-700F04F97D79Q35591562-0956ADC0-7A9A-4FE3-B5BD-1ACBA47EB9DBQ35653078-5B3DE1F4-7C5A-4E5B-9C0A-668DCC3DADD8Q35735022-A4E1A1D5-D766-4912-B911-6E58DAD89333Q35761917-ECC75644-7E91-4392-892F-7584A3EADC28Q35815150-10CCAAF5-912E-470C-99CD-5DA3433E0F60Q36189413-270CF947-14E6-4DF9-B29E-F0A06139ABE6Q36604919-0DBF39A4-1368-4F4A-9BEB-637636310F40Q36813008-FFA2F20D-33DD-4E8B-9024-700445ABAD3BQ36853421-F96D1559-2C9A-4ED4-8806-EA330582B8E9Q36953375-78F01B43-A06B-401F-B403-F708383116BFQ36988138-2CFCEE56-5337-4422-8032-7D56125DAB38Q36994175-B7B24587-E060-4FD6-8AB6-63953A7EE4F0Q37079047-66115FAC-688A-4FFD-B1FD-29A5CE69617EQ37181734-53B7687B-CD9F-421C-A740-2C44F4FD227FQ37234868-F8DB7F67-BC72-40EA-A3DB-7626EAC0DA06Q37484230-62704A48-2251-4E84-9A41-025C7AA7DBBEQ37618815-2E304D51-73B7-4C86-B128-CD9497495BECQ37700096-6F3A2E63-DBC9-460B-9A3D-DE8316F48E56Q37785490-0F87A16C-A59A-463C-B505-7374D14DA6F4Q37874330-DFA2A6C1-D7EB-4F14-B611-4FAB3A4B5617Q37928566-DAB82C99-8C4D-431F-A558-1931D9B09182
P2860
Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@ast
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@en
type
label
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@ast
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@en
prefLabel
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@ast
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@en
P356
P1476
Drug insight: cancer therapy s ...... ogenous cell death mechanisms.
@en
P2093
John C Reed
P304
P356
10.1038/NCPONC0538
P577
2006-07-01T00:00:00Z